General Information of Drug Off-Target (DOT) (ID: OT1GG9FK)

DOT Name Phospholipase A2 (PLA2G1B)
Synonyms EC 3.1.1.4; Group IB phospholipase A2; Phosphatidylcholine 2-acylhydrolase 1B
Gene Name PLA2G1B
UniProt ID
PA21B_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
3ELO; 6Q42
EC Number
3.1.1.4
Pfam ID
PF00068
Sequence
MKLLVLAVLLTVAAADSGISPRAVWQFRKMIKCVIPGSDPFLEYNNYGCYCGLGGSGTPV
DELDKCCQTHDNCYDQAKKLDSCKFLLDNPYTHTYSYSCSGSAITCSSKNKECEAFICNC
DRNAAICFSKAPYNKAHKNLDTKKYCQS
Function
Secretory calcium-dependent phospholipase A2 that primarily targets dietary phospholipids in the intestinal tract. Hydrolyzes the ester bond of the fatty acyl group attached at sn-2 position of phospholipids (phospholipase A2 activity) with preference for phosphatidylethanolamines and phosphatidylglycerols over phosphatidylcholines. May play a role in the biosynthesis of N-acyl ethanolamines that regulate energy metabolism and inflammation in the intestinal tract. Hydrolyzes N-acyl phosphatidylethanolamines to N-acyl lysophosphatidylethanolamines, which are further cleaved by a lysophospholipase D to release N-acyl ethanolamines. May act in an autocrine and paracrine manner. Upon binding to the PLA2R1 receptor can regulate podocyte survival and glomerular homeostasis. Has anti-helminth activity in a process regulated by gut microbiota. Upon helminth infection of intestinal epithelia, directly affects phosphatidylethanolamine contents in the membrane of helminth larvae, likely controlling an array of phospholipid-mediated cellular processes such as membrane fusion and cell division while providing for better immune recognition, ultimately reducing larvae integrity and infectivity.
Tissue Specificity Selectively expressed in pancreas, lung, liver and kidney. Also detected at lower levels in ovary and testis.
KEGG Pathway
Glycerophospholipid metabolism (hsa00564 )
Ether lipid metabolism (hsa00565 )
Arachidonic acid metabolism (hsa00590 )
Linoleic acid metabolism (hsa00591 )
alpha-Linolenic acid metabolism (hsa00592 )
Metabolic pathways (hsa01100 )
Ras sig.ling pathway (hsa04014 )
Vascular smooth muscle contraction (hsa04270 )
Pancreatic secretion (hsa04972 )
Fat digestion and absorption (hsa04975 )
Reactome Pathway
Acyl chain remodelling of PS (R-HSA-1482801 )
Acyl chain remodelling of PE (R-HSA-1482839 )
Acyl chain remodelling of PI (R-HSA-1482922 )
Acyl chain remodelling of PG (R-HSA-1482925 )
Synthesis of PA (R-HSA-1483166 )
Acyl chain remodelling of PC (R-HSA-1482788 )
BioCyc Pathway
MetaCyc:HS10199-MONOMER

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 4 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Gentamicin DMKINJO Approved Phospholipase A2 (PLA2G1B) increases the Drug toxicity ADR of Gentamicin. [7]
Amikacin DM5PDRB Approved Phospholipase A2 (PLA2G1B) increases the Drug toxicity ADR of Amikacin. [7]
Tobramycin DMUI0CH Approved Phospholipase A2 (PLA2G1B) increases the Drug toxicity ADR of Tobramycin. [7]
Dibekacin DMTX0PZ Phase 4 Phospholipase A2 (PLA2G1B) increases the Drug toxicity ADR of Dibekacin. [7]
------------------------------------------------------------------------------------
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Phospholipase A2 (PLA2G1B). [1]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide increases the expression of Phospholipase A2 (PLA2G1B). [2]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of Phospholipase A2 (PLA2G1B). [3]
Rutin DMEHRAJ Investigative Rutin decreases the expression of Phospholipase A2 (PLA2G1B). [5]
EGTA DMW9MRO Investigative EGTA decreases the activity of Phospholipase A2 (PLA2G1B). [6]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the methylation of Phospholipase A2 (PLA2G1B). [4]
------------------------------------------------------------------------------------

References

1 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
2 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
3 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
4 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
5 Combination of metabolomics and network pharmacology analysis to decipher the mechanisms of total flavonoids of Litchi seed against prostate cancer. J Pharm Pharmacol. 2023 Jul 5;75(7):951-968. doi: 10.1093/jpp/rgad035.
6 Group IB secretory phospholipase A2 stimulates CXC chemokine ligand 8 production via ERK and NF-kappa B in human neutrophils. J Immunol. 2004 Nov 15;173(10):6433-9. doi: 10.4049/jimmunol.173.10.6433.
7 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.